Association between time of hospitalization with acute myocardial infarction and in-hospital mortality.


Journal

European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263

Informations de publication

Date de publication:
14 04 2019
Historique:
received: 19 06 2018
revised: 01 08 2018
accepted: 26 11 2018
pubmed: 31 1 2019
medline: 29 8 2020
entrez: 31 1 2019
Statut: ppublish

Résumé

To study the association between time of hospitalization and in-hospital mortality for acute myocardial infarction (AMI). Patients admitted with ST-elevation myocardial infarction (STEMI) and non-STEMI (NSTEMI) across 243 hospitals in England and Wales between 1 January 2004 and 31 March 2013 were included. The outcome measure was in-hospital mortality. Adjusted odds ratios (ORs) for in-hospital mortality were estimated across six 4-hourly time periods over the 24-h clock using multilevel logistic regression, inverse-probability weighting propensity score, and instrumental variable analysis. Among 615 035 patients [median age 70.0 years, interquartile range 59.0-80.0 years; 406 519 (66.0%) men], there were 52 777 (8.8%) in-hospital deaths. At night, patients with NSTEMI were more frequently comorbid, and for STEMI had longer symptom-onset-to-reperfusion times. For STEMI, unadjusted in-hospital mortality was highest between 20:00 and 23:59 [4-h period range 8.4-9.9%; OR compared with 00:00-03:59 reference 1.13, 95% confidence interval (CI) 1.07-1.20], and for NSTEMI highest between 12:00 and 15:59 (8.0-8.8%; OR compared with 00:00-03:59 reference 1.07, 95% CI 1.03-1.12). However, these differences were only apparent in the earlier years of the study, and were attenuated by adjustment for demographics, comorbidities, and clinical presentation. Differences were not statistically significant after adjustment for acute clinical treatment provided. There is little evidence to support an association between time of hospitalization and in-hospital mortality for AMI; variation in in-hospital mortality may be explained by case mix and the use of treatments.

Identifiants

pubmed: 30698766
pii: 5301310
doi: 10.1093/eurheartj/ehy835
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1214-1221

Subventions

Organisme : Wellcome Trust
ID : 206470/Z/17/Z
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Auteurs

Jianhua Wu (J)

Division of Applied Health and Clinical Translation, School of Dentistry, University of Leeds,Leeds, UK.

Marlous Hall (M)

Department of Clinical and Population Sciences, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds UK.

Tatendashe B Dondo (TB)

Department of Clinical and Population Sciences, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds UK.

Chris Wilkinson (C)

Department of Clinical and Population Sciences, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds UK.

Peter Ludman (P)

Cardiology Department, University Hospitals Birmingham, NHS Foundation Trust, Birmingham, UK.

Mark DeBelder (M)

Department of Cardiology, The James Cook University Hospital, Middlesbrough, UK.

Keith A A Fox (KAA)

Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.

Adam Timmis (A)

NIHR Cardiovascular Biomedical Research Unit, Barts Heart Centre, London, UK.

Chris P Gale (CP)

Department of Clinical and Population Sciences, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH